Sarah Jensen, MD
Dermatology · Festus, MONPI 1639119175
Payments from drug & device makers
Across 1,041 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$6K
- AbbVie$2K
- Amgen$2K
- Arcutis Biotherapeutics, Inc.$1K
- Johnson & Johnson$1K
- E.r. Squibb & Sons, L.L.C.$1K
- plus $8K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 50 | $5,802 |
| AbbVie(2 entities) | 170 | $2,382 |
| Amgen | 87 | $1,506 |
| Arcutis Biotherapeutics, Inc. | 42 | $1,476 |
| Johnson & Johnson | 92 | $1,423 |
| E.r. Squibb & Sons, L.L.C. | 60 | $1,129 |
| Regeneron Healthcare Solutions, Inc. | 34 | $733 |
| Dermavant Sciences, Inc. | 65 | $706 |
| Prugen, Inc. Pharmaceuticals | 52 | $685 |
| LEO Pharma Inc. | 91 | $671 |
| Galderma Laboratories, L.p. | 27 | $618 |
| Lilly USA, LLC | 30 | $589 |
| Mayne Pharma Commercial LLC | 79 | $547 |
| Sun Pharmaceutical Industries Inc. | 18 | $491 |
| Journey Medical Corporation | 14 | $437 |
| Boehringer Ingelheim | 5 | $412 |
| Sanofi | 17 | $381 |
| Organogenesis Inc. | 7 | $320 |
| Pfizer | 17 | $305 |
| Novartis | 18 | $283 |
| Almirall LLC | 12 | $278 |
| Kerecis Limited | 2 | $246 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Bristol Myers Squibb | 17 | $119 |
| Incyte Corporation | 6 | $113 |
| Biofrontera Inc. | 6 | $92 |
| EPI Health, LLC | 4 | $83 |
| Organon | 6 | $56 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $56 |
| Mission Pharmacal Company | 3 | $44 |
| Genentech USA, Inc. | 2 | $38 |
| Strata Skin Sciences, Inc. | 2 | $37 |
| Merck | 1 | $15 |
How this compares
$22,198 in reported general payments places this provider in the 85th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Festus
- Melody StoneSaint Joseph$4.3M
- Milan AnadkatSaint Louis$2.4M
- Brian KimSaint Louis$2.3M
- Elaine SiegfriedSaint Louis$2.2M
- Craig LeonardiSaint Louis$1.7M
- David CleaverKirksville$789K
- Amy MusiekSaint Louis$577K
- Ann MartinSaint Louis$512K
- Jonathan CleaverKirksville$483K
- Mary GeorgeSaint Louis$400K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.